nikethamide has been researched along with Benign Neoplasms, Brain in 1 studies
Nikethamide: A central nervous system stimulant. It was formerly used in the treatment of barbiturate overdose but is now considered to be of no value for such purposes and may be dangerous. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1229)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elkharraz, K | 1 |
| Faisant, N | 1 |
| Guse, C | 1 |
| Siepmann, F | 1 |
| Arica-Yegin, B | 1 |
| Oger, JM | 1 |
| Gust, R | 1 |
| Goepferich, A | 1 |
| Benoit, JP | 1 |
| Siepmann, J | 1 |
1 other study available for nikethamide and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Drug Carriers; Drug Compounding; Drug Implants; | 2006 |